Document is current

Any future updates will be listed below

Furmonertinib combined with bevacizumab in EGFR-TKI-resistant leptomeningeal metastasis: analysis of the CSF ctDNA molecular response and survival outcomes

Crossref DOI link: https://doi.org/10.1038/s41416-026-03407-z

Published Online: 2026-04-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark